Your browser is no longer supported. Please, upgrade your browser.
Settings
PODD Insulet Corporation daily Stock Chart
PODD [NASD]
Insulet Corporation
Index- P/E- EPS (ttm)-0.40 Insider Own1.40% Shs Outstand58.78M Perf Week-3.71%
Market Cap5.77B Forward P/E289.53 EPS next Y0.34 Insider Trans-8.46% Shs Float58.12M Perf Month10.38%
Income-23.10M PEG- EPS next Q-0.13 Inst Own98.50% Short Float8.44% Perf Quarter13.39%
Sales485.60M P/S11.88 EPS this Y3.80% Inst Trans2.64% Short Ratio11.17 Perf Half Y42.18%
Book/sh2.92 P/B33.61 EPS next Y254.50% ROA-3.60% Target Price98.27 Perf Year104.74%
Cash/sh5.99 P/C16.39 EPS next 5Y25.00% ROE-20.00% 52W Range47.31 - 102.89 Perf YTD42.25%
Dividend- P/FCF- EPS past 5Y15.80% ROI-1.10% 52W High-6.50% Beta1.38
Dividend %- Quick Ratio5.20 Sales past 5Y17.00% Gross Margin60.50% 52W Low103.35% ATR2.69
Employees857 Current Ratio5.50 Sales Q/Q21.50% Oper. Margin-0.50% RSI (14)54.73 Volatility3.18% 2.88%
OptionableYes Debt/Eq0.00 EPS Q/Q35.00% Profit Margin-4.80% Rel Volume1.53 Prev Close98.15
ShortableYes LT Debt/Eq3.34 EarningsMay 03 AMC Payout- Avg Volume439.17K Price96.21
Recom2.00 SMA200.41% SMA506.75% SMA20027.65% Volume440,012 Change-1.98%
Apr-20-18Initiated Berenberg Buy $100
Feb-22-18Reiterated Barclays Overweight $85 → $90
Jan-08-18Upgrade Raymond James Mkt Perform → Outperform
Nov-03-17Upgrade Canaccord Genuity Hold → Buy $50 → $65
Sep-15-17Initiated Barclays Overweight $65
Jul-17-17Downgrade BTIG Research Buy → Neutral
May-25-17Resumed William Blair Outperform
May-22-17Resumed Piper Jaffray Overweight
Feb-28-17Reiterated Wedbush Outperform $48 → $50
Jan-06-17Upgrade Robert W. Baird Neutral → Outperform $39 → $47
Aug-04-16Reiterated Wedbush Outperform $44 → $48
Feb-26-16Upgrade The Benchmark Company Hold → Buy $30 → $40
Nov-06-15Reiterated Northland Capital Outperform $35 → $40
Nov-02-15Initiated Morgan Stanley Equal-Weight
Jul-08-15Initiated Robert W. Baird Neutral $34
May-04-15Upgrade Northland Capital Market Perform → Outperform $28 → $32
May-01-15Reiterated The Benchmark Company Buy $39 → $30
May-01-15Reiterated Oppenheimer Perform $33 → $31
Apr-15-15Reiterated Wedbush Outperform $34 → $38
Feb-27-15Downgrade Oppenheimer Outperform → Perform $39 → $33
Jun-19-18 06:00AM  Insulet to Unveil New Omnipod® DASHTM System and Present Innovative Research at the American Diabetes Association's 78th Scientific Sessions Business Wire
Jun-13-18 03:41AM  Artificial Pancreas Lifts Tandem Diabetes Investopedia
Jun-12-18 07:10AM  Complimentary Technical Snapshots on Hologic and Three More Medical Supplies Stocks ACCESSWIRE
Jun-04-18 06:00AM  Insulets Omnipod® DASH Insulin Management System Receives FDA 510(k) Clearance Business Wire
May-31-18 12:10PM  3 Stocks That Have Doubled and Still Have Room to Grow Motley Fool
07:55AM  Factors of Influence in 2018, Key Indicators and Opportunity within Insulet, Everi, Ciner Resources LP, Aluminum Corporation of China, Okta, and MYOS RENS Technology New Research Emphasizes Economic Growth GlobeNewswire
May-29-18 04:01PM  Insulet to Present at Upcoming Investor Conference Business Wire
May-28-18 10:40AM  3 Innovative Medical Technology Companies Shaking Up the Diabetes Market Motley Fool
May-25-18 12:40PM  Five Top MedTech Stocks in Diabetes Motley Fool
May-09-18 04:11AM  Edited Transcript of PODD earnings conference call or presentation 3-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-04-18 09:42AM  Insulet Delivers 21% Revenue Growth and Achieves Operating Profitability Breakeven Motley Fool
May-03-18 04:06PM  Insulet: 1Q Earnings Snapshot Associated Press
04:01PM  Insulet Reports First Quarter 2018 Revenue of $123.6 Million, Up 21% Year-Over-Year, and Gross Margin of 61.4%, Up 300 Basis Points, Exceeding Expectations Business Wire
05:00AM  Insulet Achieves Key Milestones to Support its Transition to Direct Operations in Europe on July 1, 2018 Business Wire
May-01-18 04:01PM  Insulet Establishes Two Significant Commercial Partnerships to Support its European Expansion Business Wire
Apr-10-18 11:01AM  Edited Transcript of PODD presentation 7-Mar-17 4:35pm GMT Thomson Reuters StreetEvents
Apr-05-18 07:45AM  Report: Developing Opportunities within Insulet, Karyopharm Therapeutics, Playa Hotels & Resorts N.V, Cision Ltd., Freightcar America, and COUPA SOFTWARE Future Expectations, Projections Moving into 2018 GlobeNewswire
06:00AM  Insulet to Announce First Quarter 2018 Financial Results on May 3, 2018 Business Wire
Mar-14-18 03:00AM  Insulet to Share Omnipod Clinical Data at Three Major European National Diabetes Congresses Business Wire
Mar-06-18 11:51AM  Analyst: Insulet On Track For Profitability In 2018 Benzinga
07:40AM  Report: Developing Opportunities within Public Service Enterprise Group, Nucor, Newmont Mining, Insulet, Hecla Mining, and Occidental Petroleum Future Expectations, Projections Moving into 2018 GlobeNewswire
Feb-28-18 08:00AM  Insulet Corporation to Present at Upcoming Investor Conferences Business Wire
Feb-22-18 02:31PM  Edited Transcript of PODD earnings conference call or presentation 21-Feb-18 9:30pm GMT Thomson Reuters StreetEvents
08:02AM  Insulet Pumps Out 26% Revenue Growth; Loss Narrows Motley Fool
Feb-21-18 04:15PM  Insulet reports 4Q loss Associated Press
04:01PM  Insulet Reports Fourth Quarter Revenue of $130.5 Million, Up 26%, and Gross Margin Up 210 Basis Points, Exceeding Expectations Business Wire
12:00PM  Insulet Corporation to Host Earnings Call ACCESSWIRE
10:43AM  Insulet Q4 Earnings Preview Benzinga
Feb-14-18 06:00AM  Insulet Has Strong Presence at the International ATTD Congress; Presents Positive Study Results for Its Omnipod Horizon Hybrid Closed-Loop System Business Wire
Jan-29-18 09:00AM  Insulet Corporation to Announce Fourth Quarter and Full Year 2017 Financial Results on February 21, 2018 Business Wire
Jan-15-18 06:01AM  Does Insulet Corporations (NASDAQ:PODD) Past Performance Indicate A Stronger Future? Simply Wall St.
Jan-10-18 08:05AM  See what the IHS Markit Score report has to say about Insulet Corp. Markit
Jan-09-18 08:05AM  See what the IHS Markit Score report has to say about Insulet Corp. Markit
08:00AM  Ascensia Diabetes Care Expands Strategic Alliance with Insulet Corporation by Signing Commercial Agreement PR Newswire
07:00AM  Ascensia Diabetes Care Expands Strategic Alliance with Insulet Corporation by Signing Commercial Agreement PR Newswire
Jan-08-18 02:48PM  Here's Why Insulet Corporation Jumped Today Motley Fool +13.61%
12:22PM  4 Tailwinds Driving Raymond James' Insulet Bull Case Benzinga
08:05AM  See what the IHS Markit Score report has to say about Insulet Corp. Markit
06:00AM  Medicare Part D (Prescription Drug) Plans May Now Cover Omnipod® Business Wire
Jan-02-18 08:05AM  See what the IHS Markit Score report has to say about Insulet Corp. Markit
Dec-29-17 08:03AM  See what the IHS Markit Score report has to say about Insulet Corp. Markit
Dec-22-17 08:04AM  See what the IHS Markit Score report has to say about Insulet Corp. Markit
Dec-20-17 04:01PM  Insulet Corporation to Present at Upcoming Investor Conference Business Wire
Dec-19-17 01:48PM  ETFs with exposure to Insulet Corp. : December 19, 2017 Capital Cube
Dec-18-17 08:05AM  See what the IHS Markit Score report has to say about Insulet Corp. Markit
Dec-14-17 08:05AM  See what the IHS Markit Score report has to say about Insulet Corp. Markit
07:50AM  Free Research Report as Insulets Revenue Grew 28.4% ACCESSWIRE
Dec-12-17 08:05AM  See what the IHS Markit Score report has to say about Insulet Corp. Markit
Dec-08-17 08:03AM  See what the IHS Markit Score report has to say about Insulet Corp. Markit
Dec-07-17 08:03AM  See what the IHS Markit Score report has to say about Insulet Corp. Markit
Nov-29-17 08:04AM  See what the IHS Markit Score report has to say about Insulet Corp. Markit
Nov-28-17 01:05PM  ETFs with exposure to Insulet Corp. : November 28, 2017 Capital Cube
Nov-27-17 08:06AM  See what the IHS Markit Score report has to say about Insulet Corp. Markit
Nov-22-17 08:05AM  See what the IHS Markit Score report has to say about Insulet Corp. Markit
08:00AM  Insulet Corporation to Present at Upcoming Investor Conference Business Wire
Nov-13-17 01:02PM  ETFs with exposure to Insulet Corp. : November 13, 2017 Capital Cube
08:00AM  Insulet Corporation to Present at Upcoming Investor Conference Business Wire
Nov-09-17 08:06AM  See what the IHS Markit Score report has to say about Insulet Corp. Markit
04:41AM  Edited Transcript of PODD earnings conference call or presentation 2-Nov-17 8:30pm GMT Thomson Reuters StreetEvents
Nov-08-17 08:06AM  See what the IHS Markit Score report has to say about Insulet Corp. Markit -5.71%
07:15AM  Insulet Announces Pricing of Convertible Senior Notes Due 2024 Business Wire
Nov-07-17 08:13AM  Insulet Corp. :PODD-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017 Capital Cube
Nov-06-17 04:01PM  Insulet Announces Private Offering of Convertible Senior Notes Business Wire
07:19AM  Insulet Corp. breached its 50 day moving average in a Bullish Manner : PODD-US : November 6, 2017 Capital Cube
Nov-03-17 12:22PM  Here's Why Insulet Corporation's Investors Are Pumped Motley Fool +19.43%
10:02AM  Insulet Posts 28% Revenue Growth and Raises 2017 Outlook on Soaring International Sales Motley Fool
10:00AM  Insulet Corporation (Nasdaq: PODD) to Ring The Nasdaq Stock Market Closing Bell GlobeNewswire
Nov-02-17 04:59PM  Insulet reports 3Q loss Associated Press
04:01PM  Insulet Reports Third Quarter 2017 Financial Results Business Wire
12:30PM  ETFs with exposure to Insulet Corp. : November 2, 2017 Capital Cube
11:00AM  Insulet Corporation to Host Earnings Call ACCESSWIRE
Nov-01-17 06:00AM  Insulet Corporation Raises Awareness for Diabetes Community During National Diabetes Awareness Month Business Wire
Oct-30-17 09:33AM  The 3 Best Diabetes Stocks to Buy in 2018 Motley Fool
Oct-26-17 08:21AM  Insulet Corp. breached its 50 day moving average in a Bearish Manner : PODD-US : October 26, 2017 Capital Cube
Oct-24-17 05:19PM  Lifshitz & Miller LLP Announces Investigation of AcelRx Pharmaceuticals, Inc., Bob Evans Farms, Inc., Calgon Carbon Corporation, Exa Corporation, Insulet Corporation, K12 Inc., PG&E Corporation PR Newswire
Oct-23-17 06:42PM  Robbins Arroyo LLP: Insulet Corporation (PODD) Misled Shareholders According to a Shareholder Derivative Lawsuit Business Wire
08:01AM  See what the IHS Markit Score report has to say about Insulet Corp. Markit
Oct-20-17 10:23AM  ETFs with exposure to Insulet Corp. : October 20, 2017 Capital Cube
Oct-18-17 04:04PM  Insulet and Dexcom Partner to Offer Choices for Animas Users Business Wire
Oct-17-17 08:04AM  See what the IHS Markit Score report has to say about Insulet Corp. Markit
Oct-12-17 08:03AM  See what the IHS Markit Score report has to say about Insulet Corp. Markit
Oct-09-17 11:56AM  ETFs with exposure to Insulet Corp. : October 9, 2017 Capital Cube
Oct-06-17 11:02AM  Insulet Offers Welcome Program for Animas® Users to Try Omnipod® Insulin Management System at Zero Cost Business Wire
09:05AM  Insulet Corp. :PODD-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017 Capital Cube
03:00AM  Insulet Shows Rising Price Performance With Jump To 91 RS Rating Investor's Business Daily
Oct-03-17 11:54AM  Insulet Corp. Value Analysis (NASDAQ:PODD) : October 3, 2017 Capital Cube
Oct-02-17 04:01PM  Insulet Corporation to Announce Third Quarter 2017 Financial Results on November 2, 2017 Business Wire
08:23AM  Insulet Corp. breached its 50 day moving average in a Bearish Manner : PODD-US : October 2, 2017 Capital Cube
Sep-28-17 06:00AM  Insulet Breaks Ground on New U.S. Manufacturing Facility Business Wire
Sep-13-17 07:00AM  Insulet Corporation Presents Real-World Clinical Data on the Use of Its Omnipod® Insulin Management System in Approximately 39,000 Patients Using a Cloud-Based Data Management System Business Wire
Sep-12-17 08:03AM  See what the IHS Markit Score report has to say about Insulet Corp. Markit
Sep-11-17 10:08AM  See what the IHS Markit Score report has to say about Insulet Corp. Markit
Aug-23-17 07:20AM  Earnings Review and Free Research Report: Insulet Beat Analysts Earnings Estimates and its Own Guidance on Revenues ACCESSWIRE
Aug-21-17 08:05AM  See what the IHS Markit Score report has to say about Insulet Corp. Markit
Aug-18-17 08:05AM  See what the IHS Markit Score report has to say about Insulet Corp. Markit
Aug-15-17 08:04AM  See what the IHS Markit Score report has to say about Insulet Corp. Markit
Aug-14-17 08:04AM  See what the IHS Markit Score report has to say about Insulet Corp. Markit
07:00AM  Earnings Review and Free Research Report: Hill-Roms Q3 Adjusted EPS Rose 12% Y-o-Y, Beating Expectations ACCESSWIRE
Aug-12-17 08:06AM  See what the IHS Markit Score report has to say about Insulet Corp. Markit
Aug-11-17 07:11PM  Edited Transcript of PODD earnings conference call or presentation 3-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod Insulin Management System (Omnipod System), which consists of an easy-to-use continuous insulin delivery system; and Personal Diabetes Manager, a handheld wireless device. It also customizes the Omnipod System technology platform for the delivery of drugs over a specified interval of time, at an administered volume. The company sells and markets its Omnipod System through a combination of direct sales representatives and independent distributors. Insulet Corporation was founded in 2000 and is headquartered in Billerica, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Spears Michael PSVP, QA and RAJun 13Option Exercise29.876,421191,79542,092Jun 14 04:45 PM
Spears Michael PSVP, QA and RAJun 13Sale100.006,421642,10035,671Jun 14 04:45 PM
Spears Michael PSVP, QA and RAJun 12Option Exercise29.871,07532,11036,746Jun 14 04:45 PM
Spears Michael PSVP, QA and RAJun 12Sale100.001,075107,50035,671Jun 14 04:45 PM
Petrovic ShaceyPresident and COOJun 01Sale94.721,067101,06688,293Jun 05 06:01 PM
Spears Michael PSVP, QA and RAMay 30Option Exercise29.878,071241,08143,742May 31 05:45 PM
Spears Michael PSVP, QA and RAMay 30Sale95.008,071766,74535,671May 31 05:45 PM
Spears Michael PSVP, QA and RAMay 24Option Exercise29.378,671254,68644,342May 29 04:02 PM
Spears Michael PSVP, QA and RAMay 24Sale90.008,671780,39035,671May 29 04:02 PM
Spears Michael PSVP, QA and RAMay 18Sale87.777,774682,30135,671May 22 04:14 PM
Abdel-Malek AimanEVP & Chief Technology OfficerMay 16Option Exercise31.202,39474,69328,027May 18 04:49 PM
Spears Michael PSVP, QA and RAMay 15Sale86.648,114702,99943,445May 16 04:53 PM
Colleran DavidSVP, Secretary and GCMay 15Sale86.244,956427,40537,139May 16 04:33 PM
Lemoine David ADirectorMay 01Sale84.931,08492,0648,398May 02 06:36 PM
Spears Michael PSVP, QA and RAMar 23Option Exercise29.265,166151,15753,327Mar 26 05:44 PM
Thomas Bradley AEVP Human ResourcesMar 16Sale85.003,500297,50066,828Mar 20 06:29 PM
Alpuche CharlesEVP & Chief Operations OfficerMar 15Sale84.657,090600,16942,973Mar 16 06:37 PM
Thomas Bradley AEVP Human ResourcesMar 14Sale83.817,250607,62370,328Mar 16 06:32 PM
Fallon John A.DirectorMar 14Sale84.109,000756,9139,558Mar 16 06:25 PM
Abdel-Malek AimanEVP & Chief Technology OfficerMar 13Option Exercise31.203,20599,99629,788Mar 15 06:43 PM
Petrovic ShaceyPresident and COOMar 06Sale76.811,319101,31290,017Mar 08 06:47 PM
Lemoine David ADirectorMar 06Sale76.8164149,2359,482Mar 08 06:33 PM
Thomas Bradley AEVP Human ResourcesMar 05Option Exercise32.516,150199,93780,228Mar 06 07:35 PM
MULLEN JAMES CDirectorNov 13Buy67.452,500168,6335,598Nov 14 06:03 PM
Alpuche CharlesEVP, Global ManufacturingSep 06Buy58.082,500145,21234,709Sep 07 04:55 PM